New HIV drug arrives in Zimbabwe, promising protection but testing health systems after aid cuts [SBS] ↳

Zimbabwe has become one of the first countries to roll out lenacapavir, a twice-yearly HIV prevention drug with near-total protection shown in clinical trials. But SBS News reports with community HIV response systems heavily dependent on foreign assistance now being cut, UNAIDS warns the funding gap could lead to 1.4 million new annual infections by 2030, casting doubt on whether scientific promise can translate into broad impact.